Immix Biopharma, Inc. (IMMX)
NASDAQ·Healthcare·Biotechnology
$8.27
-2.01%
Mkt Cap $463.50M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$14.50
Range $14.00 – $15.00
Implied Upside
+75.3%
Consensus $14.50 vs current $8.27
NASDAQ·Healthcare·Biotechnology
$8.27
-2.01%
Mkt Cap $463.50M
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$14.50
Range $14.00 – $15.00
+75.3%
Consensus $14.50 vs current $8.27